아기오스제약(주)
MX ˙ BMV ˙ US00847X1046
SecurityMX:AGIO / Agios Pharmaceuticals, Inc.
InstitutionNorthern Trust Corp
Latest Disclosed Ownership509,272 shares
Latest Disclosed Value $ 17,228,672
Northern Trust Corp reports 0.51% decrease in ownership of AGIO / Agios Pharmaceuticals, Inc.

On May 14, 2026 - Northern Trust Corp filed a 13F-HR form disclosing ownership of 509,272 shares of Agios Pharmaceuticals, Inc. (MX:AGIO) valued at $17,228,672 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 511,901 shares of Agios Pharmaceuticals, Inc.. This represents a change in shares of -0.51% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 509,272 -2,629 -0.51 17,229 23.65 0.0005
2026-02-17 2025-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 511,901 -43,509 -7.83 13,934 -37.50 0.0004
2025-11-14 2025-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 555,410 -1,395 -0.25 22,294 20.38 0.0029
2025-08-13 2025-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 556,805 -19,453 -3.38 18,519 9.68 0.0025
2025-05-13 2025-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 576,258 -19,222 -3.23 16,884 -13.71 0.0025
2025-02-14 2024-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 595,480 5,372 0.91 19,567 -25.37 0.0028
2024-11-13 2024-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 590,108 3,842 0.66 26,218 3.71 0.0043
2024-08-14 2024-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 586,266 -4,227 -0.72 25,280 46.41 0.0043
2024-05-14 2024-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 590,493 -29,746 -4.80 17,266 25.01 0.0030
2024-02-13 2023-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 620,239 7,500 1.22 13,813 -8.92 0.0025
2023-11-13 2023-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 612,739 -96,969 -13.66 15,165 -24.54 0.0029
2023-08-11 2023-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 709,708 35,399 5.25 20,099 29.76 0.0039
2023-05-15 2023-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 674,309 -14,708 -2.13 15,489 -19.95 0.0031
2023-02-13 2022-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 689,017 15,944 2.37 19,348 1.64 0.0041
2022-11-14 2022-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 673,073 141,627 26.65 19,035 61.55 0.0043
2022-08-12 2022-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 531,446 -5,877 -1.09 11,783 -24.67 0.0025
2022-05-13 2022-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 537,323 -94,964 -15.02 15,641 -24.74 0.0028
2022-02-08 2021-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 632,287 27,650 4.57 20,783 -25.52 0.0034
2021-11-15 2021-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 604,637 -15,555 -2.51 27,904 -18.36 0.0049
2021-08-13 2021-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 620,192 328,821 112.85 34,179 127.18 0.0060
2021-05-12 2021-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 291,371 5,483 1.92 15,045 21.45 0.0028
2021-02-11 2020-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 285,888 -2,512 -0.87 12,388 22.73 0.0024
2020-11-16 2020-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 288,400 -16,377 -5.37 10,094 -38.07 0.0022
2020-08-14 2020-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 304,777 -33,604 -9.93 16,299 35.76 0.0039
2020-05-14 2020-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 338,381 17,542 5.47 12,006 -21.63 0.0034
2020-02-14 2019-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 320,839 29,421 10.10 15,320 62.25 0.0034
2019-11-13 2019-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 291,418 -8,236 -2.75 9,442 -36.83 0.0023
2019-08-13 2019-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 299,654 50,908 20.47 14,947 -10.90 0.0035
2019-05-13 2019-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 248,746 3,772 1.54 16,776 48.51 0.0041
2019-02-12 2018-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 244,974 -535 -0.22 11,296 -40.34 0.0032
2018-11-14 2018-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 245,509 -3,480 -1.40 18,934 -9.72 0.0046
2018-09-18 2018-06-30 13F/A-1 AGIOS PHARMACEUTICALS COM 00847X104 248,989 -20,119 -7.48 20,973 -4.70 0.0053
2018-08-14 2018-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 252,631 -16,477 21,280
2018-05-09 2018-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 269,108 35,708 15.30 22,008 64.95 0.0057
2018-02-14 2017-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 233,400 4,774 2.09 13,342 -12.57 0.0034
2017-11-13 2017-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 228,626 -4,176 -1.79 15,261 27.42 0.0040
2017-08-11 2017-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 232,802 55,560 31.35 11,977 15.72 0.0033
2017-05-12 2017-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 177,242 18,745 11.83 10,350 56.49 0.0030
2017-02-13 2016-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 158,497 7,030 4.64 6,614 -17.32 0.0020
2016-11-09 2016-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 151,467 27,151 21.84 8,000 53.61 0.0025
2016-08-12 2016-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 124,316 12,687 11.37 5,208 14.92 0.0017
2016-08-19 2016-03-31 13F/A-1 AGIOS PHARMACEUTICALS COM 00847X104 111,629 -6,665 -5.63 4,532 -40.99 0.0015
2016-05-13 2016-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 111,629 4,532
2016-02-12 2015-12-31 13F Agios Pharmaceuticals I COMM 00847X104 118,294 -1,275 -1.07 7,680 -9.02 0.0025
2015-11-12 2015-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 119,569 -37,461 -23.86 8,441 -51.63 0.0028
2015-08-13 2015-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 157,030 -18,605 -10.59 17,452 5.37 0.0118
2015-05-14 2015-03-31 13F Agios Pharmaceuticals I COMM 00847X104 175,635 10,815 6.56 16,562 -10.31 0.0050
2015-02-12 2014-12-31 13F Agios Pharmaceuticals I COM 00847X104 164,820 19,036 13.06 18,466 106.46 0.0056
2014-11-13 2014-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 145,784 46,091 46.23 8,944 95.80 0.0028
2014-08-14 2014-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 99,693 10,244 11.45 4,568 30.44 0.0014
2014-05-14 2014-03-31 13F AGIOS PHARMACEUTICALS COMM 00847X104 89,449 -5,981 -6.27 3,502 53.26 0.0011
2014-02-21 2013-12-31 13F/A-1 AGIOS PHARMACEUTICALS COM 00847X104 95,430 59,837 168.11 2,285 129.65 0.0007
2014-02-12 2013-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 95,430 2,285
2013-11-13 2013-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 35,593 35,593 995 0.0004
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.